Application Information

This drug has been submitted to the FDA under the reference 021507/002.

Names and composition

"PREVACID NAPRAPAC 250 (COPACKAGED)" is the commercial name of a drug composed of LANSOPRAZOLE and NAPROXEN.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021507/002 PREVACID NAPRAPAC 250 (COPACKAGED) LANSOPRAZOLE; NAPROXEN CAPSULE, DELAYED REL PELLETS, TABLET/ORAL 15MG,N per A and N per A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021507/002 PREVACID NAPRAPAC 250 (COPACKAGED) LANSOPRAZOLE; NAPROXEN CAPSULE, DELAYED REL PELLETS, TABLET/ORAL 15MG,N per A and N per A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
021507/003 PREVACID NAPRAPAC 375 (COPACKAGED) LANSOPRAZOLE; NAPROXEN CAPSULE, DELAYED REL PELLETS, TABLET/ORAL 15MG,N per A and N per A,375MG
021507/004 PREVACID NAPRAPAC 500 (COPACKAGED) LANSOPRAZOLE; NAPROXEN CAPSULE, DELAYED REL PELLETS, TABLET/ORAL 15MG,N per A and N per A,500MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved